Patent · US Active

In vivo imaging compounds

US7799947B2 · kind B2 · utility

0Cited by
3References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 28, 2006
Grant dateSep 21, 2010
Priority date—
Expiry dateNov 28, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C257/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a compound of formula (I) having use for in vivo imaging of the NR2B subtype of the NMDA receptor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.